Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Cash & Equivalents (2024 - 2026)

Updated

Revium Rx's Cash & Equivalents came in at $842,000 for Q2 2026.

Analysis

Revium Rx (RVRC) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Revium Rx's Cash & Equivalents was $1.68 million, down 48.7% from FY2024.

  • Going back by year, Cash & Equivalents was $3.27 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Revium Rx 86.84 Mn 86.00 Mn - 842,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 842,000.00
Dec 31, 2025 1.68 Mn
Dec 31, 2024 3.27 Mn
API Access

Revium Rx Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RVRC&period=max&api_key=YOUR_API_KEY